The resurgence of research into psychedelics for medical purposes has sparked heightened curiosity surrounding fungi containing psilocybin. Psilocybin, along with its active metabolite psilocin, is currently undergoing extensive clinical trials to explore its potential in treating conditions such as depression, PTSD, addiction recovery, and smoking cessation, among others. With this renewed interest, it becomes imperative to delve into the chemistry of these tryptamines and consider appropriate sample preparation, storage, and handling conditions. Join Danielle St. Germaine, a scientist from Cayman’s Forensic Chemistry Division, as she delves into the biosynthesis, analytical considerations, challenges, and recommendations for handling and preparation of psilocybin and psilocin.
